Prevalence of high and low level mupirocin resistance among staphylococcal isolates from skin infection in a tertiary care hospital

Journal of Clinical and Diagnostic Research

Volumn 7, Issue 2, 2013, Pages 238-242

  Jayakumar, S ^a   Meerabai, M ^a   Shameem Banu, A S ^a   Mathew, Renu ^a   Kalyani, M ^a   Binesh Lal, Y ^a  

^a SAVEETHA MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

Coagulase negative staphylococcus (CoNS); High and low level mupirocin resistance; Methicillin resistant staphylococcus aureus (MRSA)

Indexed keywords

CEFOXITIN; METICILLIN; NOVOBIOCIN; POLYMYXIN B; PSEUDOMONIC ACID;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; COAGULASE NEGATIVE STAPHYLOCOCCUS; DISK DIFFUSION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PREVALENCE; PUS; SKIN INFECTION; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STRAIN DIFFERENCE; TERTIARY HEALTH CARE; WOUND FLUID;

EID: 84873928585     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2013/4694.2736     Document Type: Article

References (22)

1. Stevens DL, Bisno AL, Chambers HF, Everett ED, Dellinger P, Goldstein EJC et al. Practice Guidelines for the Diagnosis and Management of Skin and Soft-Tissue Infections. Clin Infect Dis. 2005; 41:1373-406.
2. Patel JB, Gorwitz RJ, Jernigan JA. Mupirocin Resistance. Clin Infect Dis. 2009; 49:935-41.
3. Cookson D. The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice. J Antimicrob Chemother. 1998; 41:11-18.
4. Rahman M, Noble WC, Cookson B. Mupirocin-resistant Staphylococcus aureus. Lancet. ii 1987; 387
5. Schmitz FJ, Lindenlauf E, Hofmann B, Fluit AC, Verhoef J, Heinz HP et al. The prevalence of low and high-level mupirocin resistance in Staphylococci from 19 European hospitals. J Antimicrobial Chemother. 1998; 42:489-95.
6. Engelman R, Shahian D, Shemin R, Guy ST, Bratzler D, Edwards F et al. The Society of Thoracic Surgeons practice guideline series: antibiotic prophylaxis in cardiac surgery. II. Antibiotic choice. Ann Thorac Surg. 2007; 83:1569-76.
7. Van Rijen M, Bonten M, Wenzel R, Kluytmans J. Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers. Cochrane Database Syst Rev. 2008 (4): CD006216.
8. Simor AE, Stuart TL, Louie L, Watt C, Ofner-Agostini M, Gravel D et al. Canadian Nosocomial Infection Surveillance Program. Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals. Antimicrob Agents Chemother. 2007;51:3880-86.
9. Mody L, Kauffman CA, McNeil SA, Galecki AT, Bradley SF. Mupirocin-based decolonization of Staphylococcus aureus carriers in residents of 2 long-term care facilities: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis. 2003; 37: 1467-74.
10. Fuchs PC, Jones RN, Barry AL. Interpretive criteria for disk diffusion susceptibility testing of mupirocin, a topical antibiotic. J Clin Microbiol. 1990; 28:608-09.
11. de Oliveira NE, Cardozo AP, Marques De A, Dos Santos KR, Giambiagi-de Marval M. Interpretive criteria to differentiate low-and high-level mupirocin resistance in Staphylococcus aureus. J Med Microbiol. 2007; 56:937-39.
12. Eltringham I. Mupirocin resistance and Methicillin-resistant Staphylococcus aureus (MRSA). J Hosp Infect. 1997; 35:1-8.
13. Rahman M, Connolly S, Noble WC, Cookson B, Phillips I. Diversity of Staphylococci exhibiting high-level resistance to mupirocin. J Med Microbiol. 1990; 33:97-100.
14. Udo EE, Jacob LE, Mokadas EM. Conjugative transfer of High-Level mupirocin resistance from Staphylococcus haemolyticus to other Staphylococci. Antimicrob Agents Chemother. 1997; 41:693-95
15. Winn WC, Allen SD, Janda WM, Koneman EW, Procop GW, Schreckenberger PC Woods G. Color atlas and textbook of diagnostic microbiology. 6th edition. Chapter 12 Gram Positive Cocci. Part I: Staphylococci and Related Gram Positive Cocci. 623-671, Philadelphia, Lippincott Williams and Wilkins 2006.
16. Performance Standards for Antimicrobial Susceptibility Testing: 20th Informational Supplement, Clinical and Laboratory Standards Institute (CLSI) M100-S20: Vol. 30, No1. Wayne, PA: Clinical and Laboratory Standards Institute; 2010.
17. Mandal A. Broth Dilution Test. In: Antimicrobials in Laboratory Medicine. Rattan A ed B I. Churchill Livingstone Pvt Ltd, 2000: 85.
18. Oommen SK, Appalaraju B, Jinsha K. Mupirocin resistance in clinical isolates of Staphylococci in a tertiary care centre in south India. Ind J med microbial. 2011; 28 (4):372-75
19. Bukharie HA, Abdelhadi MS: The epidemiology of Methicillin resistant Staphylococcus aureus at a Saudi University Hospital. Microb Drug Resist. 2001; 7(4):413-16.
20. Nizamuddin S, Irfan S, Zafar A. Evaluation of prevalence of low and high level Mupirocin resistance in Methicillin Resistant Staphylococcus aureus isolates at a tertiary care hospital Department of Pathology and Microbiology, Aga Khan University Hospital, Karachi, Pakistan. J Pak Med Assoc. 2011; 61(6):519-21.
21. Park SY, Kim SM, Park SD. The Prevalence, Genotype and Antimicrobial Susceptibility of High-and Low-Level Mupirocin Resistant Methicillin-Resistant Staphylococcus aureus. Ann Dermatol. 2012;24(1):32-38.
22. Yun HJ, Lee SW, Yoon GM, Kim SY, Choi S, Lee YS et al. Prevalence and mechanisms of low-and high-level mupirocin resistance in Staphylococci isolated from a Korean hospital. J Antimicrob Chemother. 2003; 51:619-23.